These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Rapid, simple, quantitative, and highly sensitive antibody detection for lyme disease. Burbelo PD; Issa AT; Ching KH; Cohen JI; Iadarola MJ; Marques A Clin Vaccine Immunol; 2010 Jun; 17(6):904-9. PubMed ID: 20392886 [TBL] [Abstract][Full Text] [Related]
24. Quantitative multiplexed strategies for human Lyme disease serological testing. Chou E; Minor A; Cady NC Exp Biol Med (Maywood); 2021 Jun; 246(12):1388-1399. PubMed ID: 33794698 [TBL] [Abstract][Full Text] [Related]
25. The Accuracy of Diagnostic Tests for Lyme Disease in Humans, A Systematic Review and Meta-Analysis of North American Research. Waddell LA; Greig J; Mascarenhas M; Harding S; Lindsay R; Ogden N PLoS One; 2016; 11(12):e0168613. PubMed ID: 28002488 [TBL] [Abstract][Full Text] [Related]
26. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE. Liang FT; Steere AC; Marques AR; Johnson BJ; Miller JN; Philipp MT J Clin Microbiol; 1999 Dec; 37(12):3990-6. PubMed ID: 10565920 [TBL] [Abstract][Full Text] [Related]
27. Clinical evaluation of a Borrelia modified two-tiered testing (MTTT) shows increased early sensitivity for Borrelia burgdorferi but not other endemic Borrelia species in a high incidence region for Lyme disease in Wisconsin. Sabin AP; Scholze BP; Lovrich SD; Callister SM Diagn Microbiol Infect Dis; 2023 Jan; 105(1):115837. PubMed ID: 36370542 [TBL] [Abstract][Full Text] [Related]
28. Recombinant OspC from Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii in the serodiagnosis of Lyme borreliosis. Panelius J; Lahdenne P; Heikkilä T; Peltomaa M; Oksi J; Seppälä I J Med Microbiol; 2002 Sep; 51(9):731-739. PubMed ID: 12358063 [TBL] [Abstract][Full Text] [Related]
29. Persistent Anti- Markowicz M; Reiter M; Gamper J; Stanek G; Stockinger H Microbiol Spectr; 2021 Dec; 9(3):e0102021. PubMed ID: 34937165 [TBL] [Abstract][Full Text] [Related]
30. Performance of a Modified Two-Tiered Testing Enzyme Immunoassay Algorithm for Serologic Diagnosis of Lyme Disease in Nova Scotia. Davis IRC; McNeil SA; Allen W; MacKinnon-Cameron D; Lindsay LR; Bernat K; Dibernardo A; LeBlanc JJ; Hatchette TF J Clin Microbiol; 2020 Jun; 58(7):. PubMed ID: 32321781 [TBL] [Abstract][Full Text] [Related]
31. Use of serum immune complexes in a new test that accurately confirms early Lyme disease and active infection with Borrelia burgdorferi. Brunner M; Sigal LH J Clin Microbiol; 2001 Sep; 39(9):3213-21. PubMed ID: 11526153 [TBL] [Abstract][Full Text] [Related]
32. Performance of United States serologic assays in the diagnosis of Lyme borreliosis acquired in Europe. Branda JA; Strle F; Strle K; Sikand N; Ferraro MJ; Steere AC Clin Infect Dis; 2013 Aug; 57(3):333-40. PubMed ID: 23592827 [TBL] [Abstract][Full Text] [Related]
33. Establishment of enzyme-linked immunosorbent assay using purified recombinant 83-kilodalton antigen of Borrelia burgdorferi sensu stricto and Borrelia afzelii for serodiagnosis of Lyme disease. Rauer S; Kayser M; Neubert U; Rasiah C; Vogt A J Clin Microbiol; 1995 Oct; 33(10):2596-600. PubMed ID: 8567889 [TBL] [Abstract][Full Text] [Related]
34. The VlsE (IR6) peptide ELISA in the serodiagnosis of lyme facial paralysis. Peltomaa M; McHugh G; Steere AC Otol Neurotol; 2004 Sep; 25(5):838-41. PubMed ID: 15354020 [TBL] [Abstract][Full Text] [Related]
35. Concordance of four commercial enzyme immunoassay and three immunoblot formats for the detection of Lyme borreliosis antibodies in human serum: the two-tier approach remains. Dickeson DJ; Chen SC; Sintchenko VG Pathology; 2016 Apr; 48(3):251-6. PubMed ID: 27020501 [TBL] [Abstract][Full Text] [Related]
36. Decorin binding proteins A and B in the serodiagnosis of Lyme disease in North America. Arnaboldi PM; Sambir M; Dattwyler RJ Clin Vaccine Immunol; 2014 Oct; 21(10):1426-36. PubMed ID: 25121778 [TBL] [Abstract][Full Text] [Related]
37. Humoral immune response to outer surface protein C of Borrelia burgdorferi in Lyme disease: role of the immunoglobulin M response in the serodiagnosis of early infection. Fung BP; McHugh GL; Leong JM; Steere AC Infect Immun; 1994 Aug; 62(8):3213-21. PubMed ID: 8039891 [TBL] [Abstract][Full Text] [Related]
38. Comparative reactivity of human sera to recombinant VlsE and other Borrelia burgdorferi antigens in class-specific enzyme-linked immunosorbent assays for Lyme borreliosis. Magnarelli LA; Lawrenz M; Norris SJ; Fikrig E J Med Microbiol; 2002 Aug; 51(8):649-655. PubMed ID: 12171295 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of bioMérieux's Dissociated Vidas Lyme IgM II and IgG II as a First-Tier Diagnostic Assay for Lyme Disease. Molins CR; Delorey MJ; Replogle A; Sexton C; Schriefer ME J Clin Microbiol; 2017 Jun; 55(6):1698-1706. PubMed ID: 28330884 [TBL] [Abstract][Full Text] [Related]
40. Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre. Zwerink M; Zomer TP; van Kooten B; Blaauw G; van Bemmel T; van Hees BC; Vermeeren YM; Landman GW Ticks Tick Borne Dis; 2018 Mar; 9(3):594-597. PubMed ID: 29422448 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]